Clinical Trial Update: Safety and Tolerability of Repeat Courses of IM Alefacept [Phase 3]

View source ↗

Summary

Phase 3 trial update on safety and tolerability of repeat courses of IM Alefacept in chronic plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• IM Alefacept (alefacept)

Snippet

Sponsor: Biogen | Conditions: Chronic Plaque Psoriasis | Phase 3 | Status: COMPLETED